1. Home
  2. AVTX vs STK Comparison

AVTX vs STK Comparison

Compare AVTX & STK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avalo Therapeutics Inc.

AVTX

Avalo Therapeutics Inc.

SELL

Current Price

$12.14

Market Cap

710.1M

Sector

Health Care

ML Signal

SELL

Logo Columbia Seligman Premium Technology Growth Fund Inc

STK

Columbia Seligman Premium Technology Growth Fund Inc

SELL

Current Price

$54.94

Market Cap

688.8M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
AVTX
STK
Founded
2011
N/A
Country
United States
United States
Employees
33
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
710.1M
688.8M
IPO Year
2015
2009

Fundamental Metrics

Financial Performance
Metric
AVTX
STK
Price
$12.14
$54.94
Analyst Decision
Strong Buy
Analyst Count
14
0
Target Price
★ $44.08
N/A
AVG Volume (30 Days)
★ 959.1K
49.8K
Earning Date
11-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 72.07
N/A
EPS
N/A
★ N/A
Revenue
★ $27,813,137.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 2312.27
N/A
52 Week Low
$12.51
$32.50
52 Week High
$24.27
$58.46

Technical Indicators

Market Signals
Indicator
AVTX
STK
Relative Strength Index (RSI) 22.50 57.75
Support Level N/A $50.58
Resistance Level $20.54 $55.53
Average True Range (ATR) 0.84 1.07
MACD -0.17 0.07
Stochastic Oscillator 1.24 64.51

Price Performance

Historical Comparison
AVTX
STK

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

About STK Columbia Seligman Premium Technology Growth Fund Inc

Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services.

Share on Social Networks: